本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Edgewise Therapeutics, Inc.

13.45
+0.42003.22%
盘后13.450.0200+0.15%16:32 EDT
成交量:99.08万
成交额:1,320.40万
市值:14.14亿
市盈率:-9.29
高:13.58
开:12.98
低:12.61
收:13.03
数据加载中...
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/01

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/19

重要事件披露

Form 8-K - Current report
2023/12/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/08/10

重要事件披露

Form 8-K - Current report
2023/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/15

重要事件披露

Form 8-K - Current report
2023/06/29

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/22

重要事件披露

Form 8-K - Current report
2023/06/17

重要事件披露

Form 8-K - Current report